Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001841401-26-000007

General Counsel sold 12,440 shares at an average $68.36 ($850,417)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wahl Bryan General Counsel 2026-03-17 Sale −4,084 $69.42 $283,511 72,315 D
Wahl Bryan General Counsel 2026-03-18 Sale −4,125 $68.71 $283,429 68,190 D
Wahl Bryan General Counsel 2026-03-19 Sale −4,231 $67.00 $283,477 63,959 D
Open-market sales · 12,440 sh · avg $68.36 · $850,417
Loading xslF345X06/wk-form4_1773961481.xml…